Oxford Endovascular Limited
Research and experimental development on biotechnology · Oxford
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-09-30
IXBRL · 163 source facts · 24 selected values
Validation findingsXBRL valid
Accounts to 2025-09-30
IXBRL · 163 source facts · 24 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-10-01 to 2025-09-30
- Extraction status
- complete
- Numeric facts
- 121
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2601_09769779_20250930
- Source archive
- Accounts_Monthly_Data-January2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-09-30
IXBRL · 158 source facts · 24 selected values
Validation findingsXBRL valid
Accounts to 2024-09-30
IXBRL · 158 source facts · 24 selected values
Validation findings
XBRL valid
- Reporting period
- 2023-10-01 to 2024-09-30
- Extraction status
- complete
- Numeric facts
- 118
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2507_09769779_20240930
- Source archive
- Accounts_Monthly_Data-July2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-09-30
IXBRL · 173 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2023-09-30
IXBRL · 173 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2022-10-01 to 2023-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 130
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_09769779_20230930
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2022-09-30
IXBRL · 175 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2022-09-30
IXBRL · 175 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2021-10-01 to 2022-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 133
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0012_09769779_20220930
- Source archive
- Accounts_Monthly_Data-April2023.zip
Accounts to 2021-09-30
IXBRL · 180 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2021-09-30
IXBRL · 180 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2020-10-01 to 2021-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 139
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0103_09769779_20210930
- Source archive
- Accounts_Monthly_Data-February2022.zip
Accounts to 2020-09-30
IXBRL · 136 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2020-09-30
IXBRL · 136 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2019-10-01 to 2020-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 93
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0091_09769779_20200930
- Source archive
- Accounts_Monthly_Data-June2021.zip
Accounts to 2019-09-30
IXBRL · 119 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2019-09-30
IXBRL · 119 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2018-10-01 to 2019-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 79
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0079_09769779_20190930
- Source archive
- Accounts_Monthly_Data-June2020.zip
Accounts to 2018-09-30
IXBRL · 105 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2018-09-30
IXBRL · 105 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2017-10-01 to 2018-09-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 68
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0066_09769779_20180930
- Source archive
- Accounts_Monthly_Data-May2019.zip
Registered details
09769779- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-09-09
- Jurisdiction
- —
- Registered office
- 9400, GARSINGTON ROAD, OXFORD, OX4 2HN, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
2 SH01-derived rounds2024-04-03
£2,290,168 raised
£29,126,163 estimated post-money
2024-01-24
£5,515,980 raised
£28,063,262 estimated post-money
Research and innovation
2 matched grantsA next-generation hybrid flow diverter for the transformation of brain aneurysm treatmentLeadLive
Innovate UK · Collaborative R&D · 2025-05-01 – 2026-10-31
£499,859
awarded
Next Generation Flow Diverter for the Treatment of Intracranial AneurysmsLead
Innovate UK · Study · 2020-11-01 – 2022-01-31
£349,999
awarded